Relapse and death during first remission in acute myeloid leukemia.
Yanada
Masamitsu
M
Garcia-Manero
Guillermo
G
Borthakur
Gautam
G
Ravandi
Farhad
F
Kantarjian
Hagop
H
Estey
Elihu
E
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D018572:Disease-Free Survival; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D053208:Kaplan-Meier Estimate; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012074:Remission Induction; D012306:Risk; D016019:Survival Analysis; D016896:Treatment Outcome
D003561:Cytarabine